Review



ecg data  (Digitimer North America LLC)


Bioz Verified Symbol Digitimer North America LLC is a verified supplier
Bioz Manufacturer Symbol Digitimer North America LLC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Digitimer North America LLC ecg data
    Ecg Data, supplied by Digitimer North America LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ecg data/product/Digitimer North America LLC
    Average 90 stars, based on 1 article reviews
    ecg data - by Bioz Stars, 2026-06
    90/100 stars

    Images



    Similar Products

    86
    Physiodata Inc electrocardiogram ecg data
    Electrocardiogram Ecg Data, supplied by Physiodata Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/electrocardiogram ecg data/product/Physiodata Inc
    Average 86 stars, based on 1 article reviews
    electrocardiogram ecg data - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Kaggle Inc kaggle ecg data set
    Kaggle Ecg Data Set, supplied by Kaggle Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/kaggle ecg data set/product/Kaggle Inc
    Average 86 stars, based on 1 article reviews
    kaggle ecg data set - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Fukuda Denshi Co mbf 1000 ecg data management system
    (A) Representative <t>electrocardiogram</t> for determining PTFV1. PTFV1 (mm∙s) was calculated by the duration (s) of the terminal negative part of the P wave in lead V1 multiplied by the absolute value of its amplitude (mm). (B) Distribution of PTFV1 in patients with CAD who underwent PCI. The red bars indicate abnormal PTFV1, and the blue bars show normal PTFV1. CAD = coronary artery disease, PCI = percutaneous coronary intervention, and PTFV1 = P-wave terminal force in V1. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Mbf 1000 Ecg Data Management System, supplied by Fukuda Denshi Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mbf 1000 ecg data management system/product/Fukuda Denshi Co
    Average 86 stars, based on 1 article reviews
    mbf 1000 ecg data management system - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Biogen Inc ecg data
    (A) Representative <t>electrocardiogram</t> for determining PTFV1. PTFV1 (mm∙s) was calculated by the duration (s) of the terminal negative part of the P wave in lead V1 multiplied by the absolute value of its amplitude (mm). (B) Distribution of PTFV1 in patients with CAD who underwent PCI. The red bars indicate abnormal PTFV1, and the blue bars show normal PTFV1. CAD = coronary artery disease, PCI = percutaneous coronary intervention, and PTFV1 = P-wave terminal force in V1. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Ecg Data, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ecg data/product/Biogen Inc
    Average 86 stars, based on 1 article reviews
    ecg data - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Pfizer Inc ecg monitoring data
    (A) Representative <t>electrocardiogram</t> for determining PTFV1. PTFV1 (mm∙s) was calculated by the duration (s) of the terminal negative part of the P wave in lead V1 multiplied by the absolute value of its amplitude (mm). (B) Distribution of PTFV1 in patients with CAD who underwent PCI. The red bars indicate abnormal PTFV1, and the blue bars show normal PTFV1. CAD = coronary artery disease, PCI = percutaneous coronary intervention, and PTFV1 = P-wave terminal force in V1. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Ecg Monitoring Data, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ecg monitoring data/product/Pfizer Inc
    Average 86 stars, based on 1 article reviews
    ecg monitoring data - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Texas Instruments ecg data
    (A) Representative <t>electrocardiogram</t> for determining PTFV1. PTFV1 (mm∙s) was calculated by the duration (s) of the terminal negative part of the P wave in lead V1 multiplied by the absolute value of its amplitude (mm). (B) Distribution of PTFV1 in patients with CAD who underwent PCI. The red bars indicate abnormal PTFV1, and the blue bars show normal PTFV1. CAD = coronary artery disease, PCI = percutaneous coronary intervention, and PTFV1 = P-wave terminal force in V1. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Ecg Data, supplied by Texas Instruments, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ecg data/product/Texas Instruments
    Average 86 stars, based on 1 article reviews
    ecg data - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    90
    Pfizer Inc human ecg wearable on-device data storage device
    (A) Representative <t>electrocardiogram</t> for determining PTFV1. PTFV1 (mm∙s) was calculated by the duration (s) of the terminal negative part of the P wave in lead V1 multiplied by the absolute value of its amplitude (mm). (B) Distribution of PTFV1 in patients with CAD who underwent PCI. The red bars indicate abnormal PTFV1, and the blue bars show normal PTFV1. CAD = coronary artery disease, PCI = percutaneous coronary intervention, and PTFV1 = P-wave terminal force in V1. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Human Ecg Wearable On Device Data Storage Device, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ecg wearable on-device data storage device/product/Pfizer Inc
    Average 90 stars, based on 1 article reviews
    human ecg wearable on-device data storage device - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    BIOPAC ecg data acquisition module biopac mp150
    Effects of ZnO NPs on mice <t>ECG.</t> (A) Representative images showed the effects of ZnO NPs-40 at different doses and exposure duration on <t>ECG</t> in mice. (B) Representative images showed the effects of ZnO NPs-100 at different doses and exposure duration on ECG in mice. (C) Changes of PR-interval after different doses of ZnO NPs-40 for 0-60 min. (D) Changes of PR-interval after different doses of ZnO NPs-100 for 0-60 min. P, P wave; R, R wave; QRS-T, QRS complex and T wave; PVC, premature ventricular contractions; AVB, atrioventricular conduction block. * P < 0.05, ** P < 0.01, *** P < 0.001. n = 6 for control group; n = 6 for ZnO NPs-40 at 5 mg/kg group and 8 mg/kg group; n = 11 for ZnO NPs-40 at 10 mg/kg group; n = 7 for ZnO NPs-40 at 20 mg/kg group; n = 6 for ZnO NPs-100 at 5 mg/kg group, 10 mg/kg group and 20 mg/kg group; n = 10 for ZnO NPs-100 at 30 mg/kg group.
    Ecg Data Acquisition Module Biopac Mp150, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ecg data acquisition module biopac mp150/product/BIOPAC
    Average 90 stars, based on 1 article reviews
    ecg data acquisition module biopac mp150 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Digitimer North America LLC ecg data
    Effects of ZnO NPs on mice <t>ECG.</t> (A) Representative images showed the effects of ZnO NPs-40 at different doses and exposure duration on <t>ECG</t> in mice. (B) Representative images showed the effects of ZnO NPs-100 at different doses and exposure duration on ECG in mice. (C) Changes of PR-interval after different doses of ZnO NPs-40 for 0-60 min. (D) Changes of PR-interval after different doses of ZnO NPs-100 for 0-60 min. P, P wave; R, R wave; QRS-T, QRS complex and T wave; PVC, premature ventricular contractions; AVB, atrioventricular conduction block. * P < 0.05, ** P < 0.01, *** P < 0.001. n = 6 for control group; n = 6 for ZnO NPs-40 at 5 mg/kg group and 8 mg/kg group; n = 11 for ZnO NPs-40 at 10 mg/kg group; n = 7 for ZnO NPs-40 at 20 mg/kg group; n = 6 for ZnO NPs-100 at 5 mg/kg group, 10 mg/kg group and 20 mg/kg group; n = 10 for ZnO NPs-100 at 30 mg/kg group.
    Ecg Data, supplied by Digitimer North America LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ecg data/product/Digitimer North America LLC
    Average 90 stars, based on 1 article reviews
    ecg data - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    BIOPAC ecg data recording system
    Effects of ZnO NPs on mice <t>ECG.</t> (A) Representative images showed the effects of ZnO NPs-40 at different doses and exposure duration on <t>ECG</t> in mice. (B) Representative images showed the effects of ZnO NPs-100 at different doses and exposure duration on ECG in mice. (C) Changes of PR-interval after different doses of ZnO NPs-40 for 0-60 min. (D) Changes of PR-interval after different doses of ZnO NPs-100 for 0-60 min. P, P wave; R, R wave; QRS-T, QRS complex and T wave; PVC, premature ventricular contractions; AVB, atrioventricular conduction block. * P < 0.05, ** P < 0.01, *** P < 0.001. n = 6 for control group; n = 6 for ZnO NPs-40 at 5 mg/kg group and 8 mg/kg group; n = 11 for ZnO NPs-40 at 10 mg/kg group; n = 7 for ZnO NPs-40 at 20 mg/kg group; n = 6 for ZnO NPs-100 at 5 mg/kg group, 10 mg/kg group and 20 mg/kg group; n = 10 for ZnO NPs-100 at 30 mg/kg group.
    Ecg Data Recording System, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ecg data recording system/product/BIOPAC
    Average 90 stars, based on 1 article reviews
    ecg data recording system - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Representative electrocardiogram for determining PTFV1. PTFV1 (mm∙s) was calculated by the duration (s) of the terminal negative part of the P wave in lead V1 multiplied by the absolute value of its amplitude (mm). (B) Distribution of PTFV1 in patients with CAD who underwent PCI. The red bars indicate abnormal PTFV1, and the blue bars show normal PTFV1. CAD = coronary artery disease, PCI = percutaneous coronary intervention, and PTFV1 = P-wave terminal force in V1. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Journal: International Journal of Cardiology. Cardiovascular Risk and Prevention

    Article Title: Prevalence, associated factors, and prognostic value of P wave abnormality in patients with coronary artery disease

    doi: 10.1016/j.ijcrp.2025.200533

    Figure Lengend Snippet: (A) Representative electrocardiogram for determining PTFV1. PTFV1 (mm∙s) was calculated by the duration (s) of the terminal negative part of the P wave in lead V1 multiplied by the absolute value of its amplitude (mm). (B) Distribution of PTFV1 in patients with CAD who underwent PCI. The red bars indicate abnormal PTFV1, and the blue bars show normal PTFV1. CAD = coronary artery disease, PCI = percutaneous coronary intervention, and PTFV1 = P-wave terminal force in V1. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: These parameters were also automatically analyzed by the MBF-1000 ECG Data Management System (Fukuda Denshi Co., Ltd., Tokyo, Japan) in 1179 patients.

    Techniques:

    Effects of ZnO NPs on mice ECG. (A) Representative images showed the effects of ZnO NPs-40 at different doses and exposure duration on ECG in mice. (B) Representative images showed the effects of ZnO NPs-100 at different doses and exposure duration on ECG in mice. (C) Changes of PR-interval after different doses of ZnO NPs-40 for 0-60 min. (D) Changes of PR-interval after different doses of ZnO NPs-100 for 0-60 min. P, P wave; R, R wave; QRS-T, QRS complex and T wave; PVC, premature ventricular contractions; AVB, atrioventricular conduction block. * P < 0.05, ** P < 0.01, *** P < 0.001. n = 6 for control group; n = 6 for ZnO NPs-40 at 5 mg/kg group and 8 mg/kg group; n = 11 for ZnO NPs-40 at 10 mg/kg group; n = 7 for ZnO NPs-40 at 20 mg/kg group; n = 6 for ZnO NPs-100 at 5 mg/kg group, 10 mg/kg group and 20 mg/kg group; n = 10 for ZnO NPs-100 at 30 mg/kg group.

    Journal: Frontiers in Cardiovascular Medicine

    Article Title: ZnO nanoparticles induce acute arrhythmia and heart failure in mice by disturbing cardiac ion channels

    doi: 10.3389/fcvm.2025.1569265

    Figure Lengend Snippet: Effects of ZnO NPs on mice ECG. (A) Representative images showed the effects of ZnO NPs-40 at different doses and exposure duration on ECG in mice. (B) Representative images showed the effects of ZnO NPs-100 at different doses and exposure duration on ECG in mice. (C) Changes of PR-interval after different doses of ZnO NPs-40 for 0-60 min. (D) Changes of PR-interval after different doses of ZnO NPs-100 for 0-60 min. P, P wave; R, R wave; QRS-T, QRS complex and T wave; PVC, premature ventricular contractions; AVB, atrioventricular conduction block. * P < 0.05, ** P < 0.01, *** P < 0.001. n = 6 for control group; n = 6 for ZnO NPs-40 at 5 mg/kg group and 8 mg/kg group; n = 11 for ZnO NPs-40 at 10 mg/kg group; n = 7 for ZnO NPs-40 at 20 mg/kg group; n = 6 for ZnO NPs-100 at 5 mg/kg group, 10 mg/kg group and 20 mg/kg group; n = 10 for ZnO NPs-100 at 30 mg/kg group.

    Article Snippet: 8–10 weeks male C57BL/6J mice were anesthetized with isoflurane, and ECGs were collected using a BIOPAC MP150 ECG data acquisition module (BIOPAC Systems, Inc., Goleta, CA, USA) before and after exposure to ZnO NPs for up to 60 min. ZnO NPs-40 were intravenously injected at doses of 5, 8, 10, and 20 mg/kg, while ZnO NPs-100 were administered at doses of 5, 10, 20, and 30 mg/kg.

    Techniques: Blocking Assay, Control